Clarametyx today announced positive topline data from a Phase 1b/2a trial evaluating its novel antibody therapy, CMTX-101, in cystic fibrosis (CF).

Pooled patients treated with TTI-101 demonstrated a 9.4% decrease from baseline in fibrosis score at week 12, compared to a 2 ...

This means that early diagnostic tests, particularly in the first 42 hours after a baby is born, can detect many health conditions before the damage begins. It also supports the baby's long-term ...

SUMMIT, N.J., Dec. 3, 2025 /PRNewswire/ -- Vascarta Inc., is pleased to share results from a new study led by researchers at the U.S. Food and Drug Administration's Center for Biologics Evaluation and ...

The experimental therapy BIO101 may help improve muscle strength in people with spinal muscular atrophy (SMA), according to new research done in laboratory models. “We demonstrated that a daily oral ...

Treatment with Endeavor Biomedicines’ experimental oral therapy taladegib (ENV-101) improved lung function in people with idiopathic pulmonary fibrosis (IPF) in a Phase 2a clinical trial, newly ...

Dear Readers, I launched the column “Dementia Caregiving 101” to be a lifeline for caregivers supporting loved ones facing the challenges of dementia. This column is dedicated to providing not only ...

Jeezy is giving back in a major way as he honors the 20th anniversary of his landmark debut album Let’s Get It: Thug Motivation 101. Staying true to the message he delivered two decades ago about ...

The provideLiquidity function in the FluidLocker.sol contract does not adequately check the contract's FLUID token balance before proceeding with liquidity provision. This can result in transaction ...

Researchers identified disability-adjusted life year (DALY)-weighted risk factors for the composite outcome that included alcohol, blood pressure, body mass index, diet, hearing loss, kidney function, ...